Plain-English translation of NCT06917924 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational research study for people newly diagnosed with ALS. Researchers will collect blood samples, perform brain imaging scans, and gather detailed medical information from 200 patients to identify genetic factors and biological markers that may explain why ALS affects people differently. By understanding these differences, doctors hope to eventually create personalized treatment plans tailored to each person's unique disease characteristics.
ALS affects different people in very different ways—some people experience weakness in their legs first, others in their arms or speech. Researchers believe genetic differences and brain changes may explain these variations. This study aims to uncover those differences so that future treatments can be customized to match each patient's specific biology, rather than using a one-size-fits-all approach.
You likely qualify if…
You likely don't qualify if…
As a participant, you would visit the research clinic every three months for about two years. At each visit, you'll have blood drawn for genetic testing, complete muscle strength and functional ability assessments, and undergo detailed neurological exams. You'll also have at least one brain MRI scan to look for changes in brain structure. The researchers will carefully track how your symptoms progress over time to see if the genetic and imaging patterns they find relate to your individual disease course.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Italy